Systematic review of factors affecting the ratios of morphine and its major metabolites
- 1 January 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 74 (1) , 43-53
- https://doi.org/10.1016/s0304-3959(97)00142-5
Abstract
In a systematic review of 57 studies with information on 1232 patients we examined the effect of age, renal impairment, route of administration, and method of analysis on the ratios of morphine-3-glucuronide:morphine (M3G:M) and morphine-6-glucuronide:morphine (M6G:M) and the relative concentrations of M3G and M6G. Across all studies the range of the ratios of metabolites to morphine was wide (0.001-504 for M3G:M, and 0-97 for M6G:M). Neonates produced morphine glucuronides at a lower rate than older children or adults. Metabolite ratios were higher in renal impairment. Routes of administration which avoided first pass metabolism (intravenous, transdermal, rectal, intramuscular, epidural and intrathecal) resulted in lower metabolite production than oral, buccal or sublingual. Metabolite production was similar for single and multiple dosing. There was no evidence of differences between methods of assay. There was a high correlation between the two glucuronide metabolites in spite of the different situations studied, supporting a single glucuronidating enzyme. Morphine was present in CSF at a fourfold higher concentration than the glucuronide metabolites.Keywords
This publication has 21 references indexed in Scilit:
- Developing a database of published reports of randomised clinical trials in pain research 1Pain, 1996
- MORPHINE-6-GLUCURONIDE DISPOSITION IN RENAL IMPAIRMENTBritish Journal of Anaesthesia, 1993
- Lack of effect of morphine-3-glucuronide on the spinal antinociceptive actions of morphine in the rat: an electrophysiological studyPain, 1993
- Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the ratPain, 1992
- Clinical Pharmacokinetics of MorphineTherapeutic Drug Monitoring, 1991
- ANALGESIC EFFICACY AND CSF PHARMACOKINETICS OF INTRATHECAL MORPHINE-6-GLUCURONIDE: COMPARISON WITH MORPHINEBritish Journal of Anaesthesia, 1990
- EXPLANATION FOR POTENCY OF REPEATED ORAL DOSES OF MORPHINE?The Lancet, 1987
- Morphine Pharmacokinetics in Renal FailureAnesthesiology, 1987
- MORPHINE-6-GLUCURONIDE, AN IMPORTANT FACTOR IN INTERPRETING MORPHINE RADIOIMMUNOASSAYSThe Lancet, 1985
- RENAL FAILURE AND THE USE OF MORPHINE IN INTENSIVE CAREThe Lancet, 1985